https://scholars.lib.ntu.edu.tw/handle/123456789/549621
標題: | Introduction of ibnfluenza vaccines | 作者: | PAO-YU CHEN WANG-HUEI SHENG |
公開日期: | 2020 | 出版社: | Society of Internal Medicine of Taiwan | 卷: | 31 | 期: | 1 | 起(迄)頁: | 7-10 | 來源出版物: | Journal of Internal Medicine of Taiwan | 摘要: | Influenza infection is a threat to human health and cause a huge healthcare burden every year. Annual influenza vaccination is the primary strategy for the prevention and control of influenza, but the influenza vaccine effectiveness (VE) varies from year to year. The potential etiologies include not only the match between the vaccine and circulating viruses but also manufacturing technologies in vaccine production. Besides, the host immunity is also an important factor to determine VE. Generally, influenza VE in older adults is less than that in young/ middle-aged adults or children. But influenza vaccination can reduce the severity of illness in all age groups of people who get vaccinated but still get sick. Meanwhile, influenza vaccination can prevent people with chronic health conditions from i complicated disease courses when they get sick. Based on current evidence, the United States Advisory Committee on Immunization Practices during the 2019-2020 season also recommend cancer patients to receive annual inactivated influenza vaccination, even those receiving immune checkpoint inhibitors. Additionally, the inactivated influenza vaccines are generally well tolerated with minor adverse events. Collectively, annual influenza vaccination is necessary for all individuals six months of age and older. ? 2020 Society of Internal Medicine of Taiwan. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092450750&doi=10.6314%2fJIMT.202002_31%281%29.03&partnerID=40&md5=cafe5e68771d070707250cccd791522f https://scholars.lib.ntu.edu.tw/handle/123456789/549621 |
ISSN: | 1016-7390 | DOI: | 10.6314/JIMT.202002_31(1).03 | SDG/關鍵字: | checkpoint kinase inhibitor; influenza vaccine; Article; cancer patient; chronic disease; disease course; disease severity; drug tolerability; groups by age; human; infection control; infection prevention; influenza; influenza vaccination; unspecified side effect; vaccine production |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。